In a short clinical trial of IGF-I treatment of adult patients with LS, we found that IGF-I had beneficial effects such as lowering blood insulin, cholesterol [64] and serum Lp (a) [65], and that it improved left heart ventricular function [66]. Here, IGF1 is linked to Leigh syndrome.